Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1995-11-21
pubmed:abstractText
We determined whether the addition of topical apraclonidine hydrochloride to eyes that are receiving maximal medical therapy but still have inadequate intraocular pressure control and that are scheduled to undergo surgery could adequately decrease intraocular pressure, postponing the need for further intervention.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0002-9394
pubmed:author
pubmed:issnType
Print
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
423-32
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7573299-Adrenergic alpha-Agonists, pubmed-meshheading:7573299-Adrenergic beta-Antagonists, pubmed-meshheading:7573299-Adult, pubmed-meshheading:7573299-Aged, pubmed-meshheading:7573299-Aged, 80 and over, pubmed-meshheading:7573299-Carbonic Anhydrase Inhibitors, pubmed-meshheading:7573299-Clonidine, pubmed-meshheading:7573299-Double-Blind Method, pubmed-meshheading:7573299-Drug Therapy, Combination, pubmed-meshheading:7573299-Female, pubmed-meshheading:7573299-Glaucoma, Open-Angle, pubmed-meshheading:7573299-Humans, pubmed-meshheading:7573299-Intraocular Pressure, pubmed-meshheading:7573299-Male, pubmed-meshheading:7573299-Middle Aged, pubmed-meshheading:7573299-Miotics, pubmed-meshheading:7573299-Ophthalmic Solutions, pubmed-meshheading:7573299-Prospective Studies, pubmed-meshheading:7573299-Sympathomimetics, pubmed-meshheading:7573299-Treatment Outcome
pubmed:year
1995
pubmed:articleTitle
Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
pubmed:affiliation
Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study